Rank | Gene Set | Z-score |
---|---|---|
1 | alpha-linolenic acid metabolic process (GO:0036109) | 4.36592074 |
2 | negative regulation of cell killing (GO:0031342) | 4.25918311 |
3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.25918311 |
4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.09255409 |
5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.09255409 |
6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.04733881 |
7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.97420573 |
8 | L-phenylalanine catabolic process (GO:0006559) | 3.97420573 |
9 | protein carboxylation (GO:0018214) | 3.92754820 |
10 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.92754820 |
11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.91476266 |
12 | complement activation, alternative pathway (GO:0006957) | 3.89014451 |
13 | L-phenylalanine metabolic process (GO:0006558) | 3.84637279 |
14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.84637279 |
15 | negative regulation of fibrinolysis (GO:0051918) | 3.84505161 |
16 | regulation of cholesterol homeostasis (GO:2000188) | 3.74964292 |
17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.72960885 |
18 | urea cycle (GO:0000050) | 3.63834221 |
19 | urea metabolic process (GO:0019627) | 3.63834221 |
20 | cysteine metabolic process (GO:0006534) | 3.63367944 |
21 | regulation of protein activation cascade (GO:2000257) | 3.63031243 |
22 | sulfur amino acid catabolic process (GO:0000098) | 3.59721408 |
23 | valine metabolic process (GO:0006573) | 3.59319880 |
24 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.54964636 |
25 | aromatic amino acid family catabolic process (GO:0009074) | 3.54585907 |
26 | regulation of complement activation (GO:0030449) | 3.49133578 |
27 | regulation of triglyceride catabolic process (GO:0010896) | 3.47748586 |
28 | high-density lipoprotein particle remodeling (GO:0034375) | 3.46810661 |
29 | negative regulation of cholesterol transport (GO:0032375) | 3.43917169 |
30 | negative regulation of sterol transport (GO:0032372) | 3.43917169 |
31 | low-density lipoprotein particle clearance (GO:0034383) | 3.40341710 |
32 | kynurenine metabolic process (GO:0070189) | 3.39799778 |
33 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.35322271 |
34 | plasma lipoprotein particle clearance (GO:0034381) | 3.34902332 |
35 | detection of other organism (GO:0098543) | 3.32525319 |
36 | detection of bacterium (GO:0016045) | 3.30787620 |
37 | reverse cholesterol transport (GO:0043691) | 3.30566005 |
38 | phospholipid efflux (GO:0033700) | 3.30310311 |
39 | regulation of fibrinolysis (GO:0051917) | 3.28677571 |
40 | nitrogen cycle metabolic process (GO:0071941) | 3.24331752 |
41 | lysine metabolic process (GO:0006553) | 3.23614162 |
42 | lysine catabolic process (GO:0006554) | 3.23614162 |
43 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.23519340 |
44 | phospholipid homeostasis (GO:0055091) | 3.23132707 |
45 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.22309059 |
46 | indole-containing compound catabolic process (GO:0042436) | 3.20513785 |
47 | indolalkylamine catabolic process (GO:0046218) | 3.20513785 |
48 | tryptophan catabolic process (GO:0006569) | 3.20513785 |
49 | bile acid biosynthetic process (GO:0006699) | 3.15217679 |
50 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.11985572 |
51 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.11985572 |
52 | modulation by symbiont of host immune response (GO:0052553) | 3.11985572 |
53 | positive regulation by symbiont of host defense response (GO:0052509) | 3.11985572 |
54 | modulation by symbiont of host defense response (GO:0052031) | 3.11985572 |
55 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.11985572 |
56 | regulation of cholesterol storage (GO:0010885) | 3.11303768 |
57 | positive regulation of lipid catabolic process (GO:0050996) | 3.10898332 |
58 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.09641278 |
59 | macrophage activation involved in immune response (GO:0002281) | 3.08194345 |
60 | glyoxylate metabolic process (GO:0046487) | 3.08090765 |
61 | tryptophan metabolic process (GO:0006568) | 3.07118605 |
62 | homocysteine metabolic process (GO:0050667) | 3.04812460 |
63 | amino-acid betaine metabolic process (GO:0006577) | 3.04425317 |
64 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.02174684 |
65 | regulation of gamma-delta T cell activation (GO:0046643) | 2.99588572 |
66 | 2-oxoglutarate metabolic process (GO:0006103) | 2.98719188 |
67 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.98244664 |
68 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.95555124 |
69 | serine family amino acid catabolic process (GO:0009071) | 2.94224223 |
70 | plasma lipoprotein particle assembly (GO:0034377) | 2.92967276 |
71 | triglyceride homeostasis (GO:0070328) | 2.92359802 |
72 | acylglycerol homeostasis (GO:0055090) | 2.92359802 |
73 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.90231987 |
74 | protein-lipid complex remodeling (GO:0034368) | 2.89908981 |
75 | macromolecular complex remodeling (GO:0034367) | 2.89908981 |
76 | plasma lipoprotein particle remodeling (GO:0034369) | 2.89908981 |
77 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.89785476 |
78 | protein-lipid complex assembly (GO:0065005) | 2.88707941 |
79 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.85320021 |
80 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.85320021 |
81 | regulation of cholesterol esterification (GO:0010872) | 2.83020230 |
82 | regulation of plasminogen activation (GO:0010755) | 2.82211528 |
83 | ethanol oxidation (GO:0006069) | 2.81925405 |
84 | detection of external biotic stimulus (GO:0098581) | 2.81140350 |
85 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.80418469 |
86 | fibrinolysis (GO:0042730) | 2.79780032 |
87 | growth hormone receptor signaling pathway (GO:0060396) | 2.79391820 |
88 | cholesterol efflux (GO:0033344) | 2.78298762 |
89 | negative regulation of lipid transport (GO:0032369) | 2.77860227 |
90 | bile acid metabolic process (GO:0008206) | 2.77797034 |
91 | immunoglobulin mediated immune response (GO:0016064) | 2.77775451 |
92 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.76709166 |
93 | activated T cell proliferation (GO:0050798) | 2.76228552 |
94 | acute-phase response (GO:0006953) | 2.76165179 |
95 | regulation of antigen processing and presentation (GO:0002577) | 2.73641719 |
96 | cholesterol homeostasis (GO:0042632) | 2.71711285 |
97 | complement activation (GO:0006956) | 2.70737128 |
98 | sterol homeostasis (GO:0055092) | 2.70578947 |
99 | apoptotic cell clearance (GO:0043277) | 2.69996471 |
100 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.68670949 |
101 | cellular extravasation (GO:0045123) | 2.68657162 |
102 | cellular modified amino acid catabolic process (GO:0042219) | 2.68297332 |
103 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.63535585 |
104 | lipoprotein metabolic process (GO:0042157) | 2.62562111 |
105 | negative regulation of interleukin-12 production (GO:0032695) | 2.61571474 |
106 | regulation of triglyceride metabolic process (GO:0090207) | 2.61459739 |
107 | neutrophil activation involved in immune response (GO:0002283) | 2.60962623 |
108 | complement activation, classical pathway (GO:0006958) | 2.59853833 |
109 | acetyl-CoA metabolic process (GO:0006084) | 2.58230892 |
110 | regulation of mast cell degranulation (GO:0043304) | 2.56902888 |
111 | response to peptidoglycan (GO:0032494) | 2.56826674 |
112 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.55807248 |
113 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.55751745 |
114 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.54428513 |
115 | positive regulation of antigen processing and presentation (GO:0002579) | 2.54362045 |
116 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.54049818 |
117 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.53982652 |
118 | detection of molecule of bacterial origin (GO:0032490) | 2.53612769 |
119 | positive regulation of fatty acid oxidation (GO:0046321) | 2.52990813 |
120 | positive regulation of lipid storage (GO:0010884) | 2.51690597 |
121 | positive thymic T cell selection (GO:0045059) | 2.51662928 |
122 | protein-lipid complex subunit organization (GO:0071825) | 2.50578493 |
123 | plasma lipoprotein particle organization (GO:0071827) | 2.50298853 |
124 | tyrosine metabolic process (GO:0006570) | 2.50038769 |
125 | cellular response to growth hormone stimulus (GO:0071378) | 2.49951316 |
126 | regulation of humoral immune response (GO:0002920) | 2.49676298 |
127 | detection of biotic stimulus (GO:0009595) | 2.49514438 |
128 | epoxygenase P450 pathway (GO:0019373) | 2.49409397 |
129 | mannose metabolic process (GO:0006013) | 2.49306633 |
130 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.49108324 |
131 | B cell receptor signaling pathway (GO:0050853) | 2.48957861 |
132 | response to muramyl dipeptide (GO:0032495) | 2.48594702 |
133 | regulation of cholesterol transport (GO:0032374) | 2.48454467 |
134 | regulation of sterol transport (GO:0032371) | 2.48454467 |
135 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.46891191 |
136 | germinal center formation (GO:0002467) | 2.44271300 |
137 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.40399176 |
138 | regulation of leukocyte degranulation (GO:0043300) | 2.40293259 |
139 | negative thymic T cell selection (GO:0045060) | 2.39174339 |
140 | positive regulation of type 2 immune response (GO:0002830) | 2.39090647 |
141 | thymic T cell selection (GO:0045061) | 2.38901372 |
142 | T cell selection (GO:0045058) | 2.38798429 |
143 | negative regulation of T cell mediated immunity (GO:0002710) | 2.37966919 |
144 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.36156758 |
145 | negative regulation of interleukin-6 production (GO:0032715) | 2.36068831 |
146 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.35454070 |
147 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.34482312 |
148 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.34080210 |
149 | regulation of mast cell activation (GO:0033003) | 2.32425928 |
150 | positive regulation of Rap GTPase activity (GO:0032854) | 2.31478100 |
151 | negative regulation of interleukin-8 production (GO:0032717) | 2.30990773 |
152 | response to type I interferon (GO:0034340) | 2.30692958 |
153 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.29527755 |
154 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.27797313 |
155 | defense response to protozoan (GO:0042832) | 2.27144155 |
156 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.25749621 |
157 | cellular response to type I interferon (GO:0071357) | 2.25061654 |
158 | type I interferon signaling pathway (GO:0060337) | 2.25061654 |
159 | positive regulation of mast cell activation (GO:0033005) | 2.23864208 |
160 | peptide catabolic process (GO:0043171) | 2.22641747 |
161 | neutrophil activation (GO:0042119) | 2.22024098 |
162 | negative T cell selection (GO:0043383) | 2.21875201 |
163 | negative regulation of innate immune response (GO:0045824) | 2.21832278 |
164 | regulation of T cell tolerance induction (GO:0002664) | 2.21748063 |
165 | regulation of extracellular matrix disassembly (GO:0010715) | 2.21562574 |
166 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.21215166 |
167 | regulation of ARF protein signal transduction (GO:0032012) | 2.19997895 |
168 | macrophage activation (GO:0042116) | 2.19966452 |
169 | leukocyte aggregation (GO:0070486) | 2.19727378 |
170 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.18612927 |
171 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.17307144 |
172 | positive T cell selection (GO:0043368) | 2.14658192 |
173 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.13299485 |
174 | microglial cell activation (GO:0001774) | 2.12321213 |
175 | granulocyte activation (GO:0036230) | 2.11432966 |
176 | regulation of regulated secretory pathway (GO:1903305) | 2.10873835 |
177 | regulation of tolerance induction (GO:0002643) | 2.10161896 |
178 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.09901694 |
179 | regulation of type 2 immune response (GO:0002828) | 2.09683691 |
180 | response to laminar fluid shear stress (GO:0034616) | 2.08924201 |
181 | diacylglycerol metabolic process (GO:0046339) | 2.07525668 |
182 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.05844341 |
183 | negative regulation of granulocyte differentiation (GO:0030853) | 2.04715923 |
184 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.03842017 |
185 | myeloid cell activation involved in immune response (GO:0002275) | 2.03188815 |
186 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.01955268 |
187 | tolerance induction (GO:0002507) | 2.01346491 |
188 | T-helper 1 type immune response (GO:0042088) | 2.00768579 |
189 | response to protozoan (GO:0001562) | 1.99779554 |
190 | adhesion of symbiont to host cell (GO:0044650) | 1.99634537 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.88378836 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.37850909 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.08988409 |
4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.68250841 |
5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.63113955 |
6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.58661680 |
7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.99495889 |
8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.66628048 |
9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.54072231 |
10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.48672080 |
11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.38218605 |
12 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.38195110 |
13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.36735895 |
14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.28239339 |
15 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.17210198 |
16 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.16538451 |
17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.03305718 |
18 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.00744280 |
19 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.93734355 |
20 | MYC_22102868_ChIP-Seq_BL_Human | 1.88007242 |
21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.81918720 |
22 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.81202865 |
23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.76562917 |
24 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.75860651 |
25 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.72104085 |
26 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.71003271 |
27 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.70999788 |
28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.69041699 |
29 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.68802751 |
30 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.67541291 |
31 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.65769871 |
32 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.63788680 |
33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.58768547 |
34 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.57918215 |
35 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.57588972 |
36 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.57412355 |
37 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.57013265 |
38 | MAF_26560356_Chip-Seq_TH1_Human | 1.56322234 |
39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.55912082 |
40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.55880299 |
41 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.55176080 |
42 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.54239267 |
43 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.53476973 |
44 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.52579040 |
45 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.51854098 |
46 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.51635587 |
47 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.51587228 |
48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.51463966 |
49 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.48925086 |
50 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.48421116 |
51 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.47719860 |
52 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.47131577 |
53 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.46469894 |
54 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.45128038 |
55 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.44039861 |
56 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.42902872 |
57 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.39987759 |
58 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.39325533 |
59 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.35828880 |
60 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.34543226 |
61 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.34267057 |
62 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.33024347 |
63 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.30905230 |
64 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.29987267 |
65 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.28982892 |
66 | UTX_26944678_Chip-Seq_JUKART_Human | 1.28776404 |
67 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28175014 |
68 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.28005206 |
69 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.27046601 |
70 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.23650265 |
71 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.23577702 |
72 | P68_20966046_ChIP-Seq_HELA_Human | 1.22416628 |
73 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22370854 |
74 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.21958489 |
75 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21777841 |
76 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.21433898 |
77 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.20988165 |
78 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.20731715 |
79 | GATA1_19941826_ChIP-Seq_K562_Human | 1.20399490 |
80 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.19358662 |
81 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18755597 |
82 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18372312 |
83 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.17753287 |
84 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.16946470 |
85 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.16323532 |
86 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.16080817 |
87 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.16019457 |
88 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.15332461 |
89 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.15273959 |
90 | MYB_26560356_Chip-Seq_TH2_Human | 1.14372224 |
91 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14154595 |
92 | * MYB_26560356_Chip-Seq_TH1_Human | 1.13968892 |
93 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13738060 |
94 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11397102 |
95 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.09931968 |
96 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09214569 |
97 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08487807 |
98 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.06954073 |
99 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06341433 |
100 | GATA2_19941826_ChIP-Seq_K562_Human | 1.05191046 |
101 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.04349557 |
102 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.03803254 |
103 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.03274204 |
104 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02856246 |
105 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02638860 |
106 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.02478919 |
107 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.02477520 |
108 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01958887 |
109 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.00939791 |
110 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.00939791 |
111 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.00282800 |
112 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00204042 |
113 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.99317436 |
114 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.99288636 |
115 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.99260761 |
116 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99163060 |
117 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98508730 |
118 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98342998 |
119 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97615778 |
120 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.97536949 |
121 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.96688225 |
122 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.96476505 |
123 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.95771098 |
124 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.95266889 |
125 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95170136 |
126 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.94960579 |
127 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.94905749 |
128 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.94475996 |
129 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.94356468 |
130 | MAF_26560356_Chip-Seq_TH2_Human | 0.93509198 |
131 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93367809 |
132 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92809753 |
133 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.90804161 |
134 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90620413 |
135 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.89677335 |
136 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.89066454 |
137 | KDM2B_26808549_Chip-Seq_K562_Human | 0.88505838 |
138 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88221669 |
139 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.88186332 |
140 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.87457513 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 4.34238046 |
2 | MP0002139_abnormal_hepatobiliary_system | 4.17298279 |
3 | MP0005365_abnormal_bile_salt | 3.24220147 |
4 | MP0003705_abnormal_hypodermis_morpholog | 3.23698009 |
5 | MP0005085_abnormal_gallbladder_physiolo | 3.03488675 |
6 | MP0009840_abnormal_foam_cell | 2.93452348 |
7 | MP0003172_abnormal_lysosome_physiology | 2.77866272 |
8 | MP0003191_abnormal_cellular_cholesterol | 2.39708660 |
9 | MP0010329_abnormal_lipoprotein_level | 2.38484876 |
10 | MP0003252_abnormal_bile_duct | 2.36259789 |
11 | MP0008438_abnormal_cutaneous_collagen | 2.28154460 |
12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.22648388 |
13 | MP0003300_gastrointestinal_ulcer | 2.21771672 |
14 | MP0003436_decreased_susceptibility_to | 1.99165972 |
15 | MP0001666_abnormal_nutrient_absorption | 1.83182969 |
16 | MP0000609_abnormal_liver_physiology | 1.82401893 |
17 | MP0002254_reproductive_system_inflammat | 1.81363397 |
18 | MP0003303_peritoneal_inflammation | 1.78871546 |
19 | MP0005083_abnormal_biliary_tract | 1.76942194 |
20 | MP0005275_abnormal_skin_tensile | 1.76756991 |
21 | MP0010234_abnormal_vibrissa_follicle | 1.75563084 |
22 | MP0000685_abnormal_immune_system | 1.74409967 |
23 | MP0004947_skin_inflammation | 1.68434887 |
24 | MP0002148_abnormal_hypersensitivity_rea | 1.66915164 |
25 | MP0001986_abnormal_taste_sensitivity | 1.59853269 |
26 | MP0003183_abnormal_peptide_metabolism | 1.59156762 |
27 | MP0010352_gastrointestinal_tract_polyps | 1.58375501 |
28 | MP0003566_abnormal_cell_adhesion | 1.55681682 |
29 | MP0005670_abnormal_white_adipose | 1.55486553 |
30 | MP0005332_abnormal_amino_acid | 1.49395232 |
31 | MP0002118_abnormal_lipid_homeostasis | 1.45935622 |
32 | MP0002138_abnormal_hepatobiliary_system | 1.43051880 |
33 | MP0001835_abnormal_antigen_presentation | 1.42192747 |
34 | MP0003806_abnormal_nucleotide_metabolis | 1.41361542 |
35 | MP0002166_altered_tumor_susceptibility | 1.36261736 |
36 | MP0004185_abnormal_adipocyte_glucose | 1.34616624 |
37 | MP0008004_abnormal_stomach_pH | 1.34286996 |
38 | MP0002060_abnormal_skin_morphology | 1.34141625 |
39 | MP0001790_abnormal_immune_system | 1.30433004 |
40 | MP0005387_immune_system_phenotype | 1.30433004 |
41 | MP0004019_abnormal_vitamin_homeostasis | 1.29985482 |
42 | MP0003879_abnormal_hair_cell | 1.29184389 |
43 | MP0004130_abnormal_muscle_cell | 1.28636220 |
44 | MP0003828_pulmonary_edema | 1.28032486 |
45 | MP0003866_abnormal_defecation | 1.27553504 |
46 | MP0005023_abnormal_wound_healing | 1.26295681 |
47 | MP0005319_abnormal_enzyme/_coenzyme | 1.26131349 |
48 | MP0005464_abnormal_platelet_physiology | 1.23053037 |
49 | MP0002796_impaired_skin_barrier | 1.22453224 |
50 | MP0003690_abnormal_glial_cell | 1.21135252 |
51 | MP0005666_abnormal_adipose_tissue | 1.20918845 |
52 | MP0001533_abnormal_skeleton_physiology | 1.20862851 |
53 | MP0005058_abnormal_lysosome_morphology | 1.19350255 |
54 | MP0003453_abnormal_keratinocyte_physiol | 1.18986637 |
55 | MP0000604_amyloidosis | 1.17230323 |
56 | MP0009643_abnormal_urine_homeostasis | 1.16410074 |
57 | MP0003195_calcinosis | 1.16376745 |
58 | MP0001853_heart_inflammation | 1.14948511 |
59 | MP0004883_abnormal_blood_vessel | 1.14502088 |
60 | MP0001800_abnormal_humoral_immune | 1.14482480 |
61 | MP0003329_amyloid_beta_deposits | 1.13969518 |
62 | MP0003656_abnormal_erythrocyte_physiolo | 1.13343093 |
63 | MP0005409_darkened_coat_color | 1.13187276 |
64 | MP0000716_abnormal_immune_system | 1.13129918 |
65 | MP0002419_abnormal_innate_immunity | 1.09033583 |
66 | MP0004858_abnormal_nervous_system | 1.08963345 |
67 | MP0005310_abnormal_salivary_gland | 1.08356576 |
68 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.06667201 |
69 | MP0000249_abnormal_blood_vessel | 1.06502871 |
70 | MP0010155_abnormal_intestine_physiology | 1.06161773 |
71 | MP0006082_CNS_inflammation | 1.06003437 |
72 | MP0001881_abnormal_mammary_gland | 1.05691632 |
73 | MP0004381_abnormal_hair_follicle | 1.04968971 |
74 | MP0001845_abnormal_inflammatory_respons | 1.04349375 |
75 | MP0008469_abnormal_protein_level | 1.03979888 |
76 | MP0005000_abnormal_immune_tolerance | 1.03955906 |
77 | MP0005025_abnormal_response_to | 1.03923937 |
78 | MP0002933_joint_inflammation | 1.03633857 |
79 | MP0009785_altered_susceptibility_to | 1.03097479 |
80 | MP0003763_abnormal_thymus_physiology | 1.01506007 |
81 | MP0004510_myositis | 1.01461441 |
82 | MP0000598_abnormal_liver_morphology | 1.01176999 |
83 | MP0009384_cardiac_valve_regurgitation | 0.98904209 |
84 | MP0002452_abnormal_antigen_presenting | 0.98339831 |
85 | MP0005451_abnormal_body_composition | 0.97924046 |
86 | MP0009764_decreased_sensitivity_to | 0.97741872 |
87 | MP0003279_aneurysm | 0.97473288 |
88 | MP0002006_tumorigenesis | 0.97382057 |
89 | MP0005076_abnormal_cell_differentiation | 0.96588374 |
90 | MP0008961_abnormal_basal_metabolism | 0.96440182 |
91 | MP0005164_abnormal_response_to | 0.96357200 |
92 | MP0008260_abnormal_autophagy | 0.96252990 |
93 | MP0001958_emphysema | 0.95382448 |
94 | MP0003045_fibrosis | 0.93647698 |
95 | MP0002723_abnormal_immune_serum | 0.91470605 |
96 | MP0005390_skeleton_phenotype | 0.90782248 |
97 | MP0002398_abnormal_bone_marrow | 0.90724775 |
98 | MP0002136_abnormal_kidney_physiology | 0.90236886 |
99 | MP0009763_increased_sensitivity_to | 0.89995253 |
100 | MP0001873_stomach_inflammation | 0.89171007 |
101 | MP0002876_abnormal_thyroid_physiology | 0.88819045 |
102 | MP0009278_abnormal_bone_marrow | 0.88764725 |
103 | MP0005535_abnormal_body_temperature | 0.88436236 |
104 | MP0005375_adipose_tissue_phenotype | 0.87759234 |
105 | MP0001501_abnormal_sleep_pattern | 0.87663971 |
106 | MP0003724_increased_susceptibility_to | 0.87375860 |
107 | MP0001216_abnormal_epidermal_layer | 0.86830317 |
108 | MP0005671_abnormal_response_to | 0.86617085 |
109 | MP0001851_eye_inflammation | 0.86100394 |
110 | MP0002405_respiratory_system_inflammati | 0.85782557 |
111 | MP0000767_abnormal_smooth_muscle | 0.85052791 |
112 | MP0001243_abnormal_dermal_layer | 0.84830949 |
113 | MP0009115_abnormal_fat_cell | 0.84679558 |
114 | MP0001663_abnormal_digestive_system | 0.84171661 |
115 | MP0000015_abnormal_ear_pigmentation | 0.83313406 |
116 | MP0001819_abnormal_immune_cell | 0.82925175 |
117 | MP0002420_abnormal_adaptive_immunity | 0.82824140 |
118 | MP0001765_abnormal_ion_homeostasis | 0.82693217 |
119 | MP0003091_abnormal_cell_migration | 0.81016728 |
120 | MP0002998_abnormal_bone_remodeling | 0.80413933 |
121 | MP0002168_other_aberrant_phenotype | 0.78896296 |
122 | MP0001849_ear_inflammation | 0.78722185 |
123 | MP0005167_abnormal_blood-brain_barrier | 0.78126944 |
124 | MP0000343_altered_response_to | 0.77601404 |
125 | MP0005448_abnormal_energy_balance | 0.77122743 |
126 | MP0003075_altered_response_to | 0.77038802 |
127 | MP0005166_decreased_susceptibility_to | 0.76293544 |
128 | MP0001664_abnormal_digestion | 0.75928915 |
129 | MP0002429_abnormal_blood_cell | 0.75662143 |
130 | MP0000689_abnormal_spleen_morphology | 0.75530615 |
131 | MP0001756_abnormal_urination | 0.75217292 |
132 | MP0002971_abnormal_brown_adipose | 0.75118277 |
133 | MP0009333_abnormal_splenocyte_physiolog | 0.74838391 |
134 | MP0005595_abnormal_vascular_smooth | 0.74423232 |
135 | MP0003448_altered_tumor_morphology | 0.74089769 |
136 | MP0000858_altered_metastatic_potential | 0.72884977 |
137 | MP0001545_abnormal_hematopoietic_system | 0.71707838 |
138 | MP0005397_hematopoietic_system_phenotyp | 0.71707838 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 4.73246410 |
2 | Xanthomatosis (HP:0000991) | 4.09019497 |
3 | Abnormality of macrophages (HP:0004311) | 3.87455061 |
4 | Myositis (HP:0100614) | 3.80162497 |
5 | Myocardial infarction (HP:0001658) | 3.60363473 |
6 | Complement deficiency (HP:0004431) | 3.59264407 |
7 | Orchitis (HP:0100796) | 3.58496150 |
8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.37827738 |
9 | Intrahepatic cholestasis (HP:0001406) | 3.36458736 |
10 | Optic neuritis (HP:0100653) | 3.31032161 |
11 | Retrobulbar optic neuritis (HP:0100654) | 3.31032161 |
12 | Recurrent abscess formation (HP:0002722) | 3.30511089 |
13 | Recurrent bacterial skin infections (HP:0005406) | 3.26524736 |
14 | Dysostosis multiplex (HP:0000943) | 3.18217850 |
15 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.18109228 |
16 | Hyperlipoproteinemia (HP:0010980) | 3.17827201 |
17 | Increased cerebral lipofuscin (HP:0011813) | 3.12444851 |
18 | Abnormality of glycolipid metabolism (HP:0010969) | 3.04823305 |
19 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.04823305 |
20 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.04823305 |
21 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.03341035 |
22 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.03341035 |
23 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.03341035 |
24 | Peritonitis (HP:0002586) | 2.99564854 |
25 | Mucopolysacchariduria (HP:0008155) | 2.92660113 |
26 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.92660113 |
27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.92082754 |
28 | Abnormality of the common coagulation pathway (HP:0010990) | 2.87996105 |
29 | Hypobetalipoproteinemia (HP:0003563) | 2.85389576 |
30 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.85182551 |
31 | Abnormality of complement system (HP:0005339) | 2.83534850 |
32 | Thin bony cortex (HP:0002753) | 2.76613406 |
33 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.75560203 |
34 | Recurrent fungal infections (HP:0002841) | 2.72212772 |
35 | Vasculitis (HP:0002633) | 2.68513493 |
36 | Systemic lupus erythematosus (HP:0002725) | 2.67011825 |
37 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.65853973 |
38 | Prolonged partial thromboplastin time (HP:0003645) | 2.62668011 |
39 | Hypoalphalipoproteinemia (HP:0003233) | 2.62577185 |
40 | Protrusio acetabuli (HP:0003179) | 2.60427905 |
41 | Epidermoid cyst (HP:0200040) | 2.60098038 |
42 | Meningitis (HP:0001287) | 2.58433932 |
43 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.58410515 |
44 | Recurrent cutaneous fungal infections (HP:0011370) | 2.58410515 |
45 | Vacuolated lymphocytes (HP:0001922) | 2.58110600 |
46 | Pulmonary infiltrates (HP:0002113) | 2.57028879 |
47 | Eczematoid dermatitis (HP:0000976) | 2.56907949 |
48 | Cerebral aneurysm (HP:0004944) | 2.56832506 |
49 | Joint hemorrhage (HP:0005261) | 2.55313052 |
50 | Hypolipoproteinemia (HP:0010981) | 2.53838778 |
51 | Recurrent skin infections (HP:0001581) | 2.52964443 |
52 | Aortic aneurysm (HP:0004942) | 2.51297932 |
53 | Hemoptysis (HP:0002105) | 2.51295001 |
54 | Emphysema (HP:0002097) | 2.49512931 |
55 | Stomatitis (HP:0010280) | 2.48367946 |
56 | Gingivitis (HP:0000230) | 2.47873961 |
57 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.46429675 |
58 | Hyperammonemia (HP:0001987) | 2.46083780 |
59 | Autoimmune thrombocytopenia (HP:0001973) | 2.42936587 |
60 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.41345624 |
61 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.38666832 |
62 | Esophageal varix (HP:0002040) | 2.36265933 |
63 | Obstructive sleep apnea (HP:0002870) | 2.35910603 |
64 | Premature rupture of membranes (HP:0001788) | 2.34151490 |
65 | Mediastinal lymphadenopathy (HP:0100721) | 2.33333653 |
66 | Prolonged bleeding time (HP:0003010) | 2.32350650 |
67 | Keratoconjunctivitis sicca (HP:0001097) | 2.30802531 |
68 | Mitral stenosis (HP:0001718) | 2.30671743 |
69 | Mitral valve prolapse (HP:0001634) | 2.30151878 |
70 | Keratoconjunctivitis (HP:0001096) | 2.25884024 |
71 | Gingival bleeding (HP:0000225) | 2.24937671 |
72 | Hyperglycinuria (HP:0003108) | 2.24477098 |
73 | Right ventricular cardiomyopathy (HP:0011663) | 2.23676741 |
74 | Hypercholesterolemia (HP:0003124) | 2.22999692 |
75 | Osteolytic defects of the hand bones (HP:0009699) | 2.21786991 |
76 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.21786991 |
77 | Gastrointestinal infarctions (HP:0005244) | 2.21374815 |
78 | Gastrointestinal stroma tumor (HP:0100723) | 2.20430934 |
79 | Cellulitis (HP:0100658) | 2.19524062 |
80 | Aortic dissection (HP:0002647) | 2.18970563 |
81 | Inflammation of the large intestine (HP:0002037) | 2.18657869 |
82 | Restrictive lung disease (HP:0002091) | 2.18022051 |
83 | Hydroxyprolinuria (HP:0003080) | 2.17632628 |
84 | Abnormality of proline metabolism (HP:0010907) | 2.17632628 |
85 | Encephalitis (HP:0002383) | 2.16992591 |
86 | Pustule (HP:0200039) | 2.16018668 |
87 | Gastrointestinal inflammation (HP:0004386) | 2.15831989 |
88 | Polycythemia (HP:0001901) | 2.15010274 |
89 | Asymmetric septal hypertrophy (HP:0001670) | 2.14859422 |
90 | Ketosis (HP:0001946) | 2.13066601 |
91 | Agammaglobulinemia (HP:0004432) | 2.09822267 |
92 | Loss of speech (HP:0002371) | 2.08563413 |
93 | Hemorrhage of the eye (HP:0011885) | 2.06240250 |
94 | Amyloidosis (HP:0011034) | 2.05395412 |
95 | Fat malabsorption (HP:0002630) | 2.05202599 |
96 | Abnormality of the fingertips (HP:0001211) | 2.04742823 |
97 | Increased mean platelet volume (HP:0011877) | 2.04229196 |
98 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.04114678 |
99 | Abnormality of glycine metabolism (HP:0010895) | 2.04114678 |
100 | Nephritis (HP:0000123) | 2.03122014 |
101 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.02430400 |
102 | Epistaxis (HP:0000421) | 2.02165708 |
103 | Acne (HP:0001061) | 2.02038296 |
104 | Ectopia lentis (HP:0001083) | 2.00870670 |
105 | Abnormality of the intrinsic pathway (HP:0010989) | 2.00280352 |
106 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.00201448 |
107 | Abnormality of purine metabolism (HP:0004352) | 2.00030315 |
108 | Chest pain (HP:0100749) | 1.99221229 |
109 | Joint stiffness (HP:0001387) | 1.98817931 |
110 | Aneurysm (HP:0002617) | 1.98583222 |
111 | Cardiovascular calcification (HP:0011915) | 1.98045767 |
112 | Alopecia of scalp (HP:0002293) | 1.97609675 |
113 | Abnormal platelet volume (HP:0011876) | 1.97565201 |
114 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.97373822 |
115 | Obstructive lung disease (HP:0006536) | 1.97207776 |
116 | Chronic obstructive pulmonary disease (HP:0006510) | 1.97207776 |
117 | Hepatocellular carcinoma (HP:0001402) | 1.94732401 |
118 | Nasal polyposis (HP:0100582) | 1.93613474 |
119 | Vascular calcification (HP:0004934) | 1.92172971 |
120 | Upper limb amyotrophy (HP:0009129) | 1.92160723 |
121 | Distal upper limb amyotrophy (HP:0007149) | 1.92160723 |
122 | Dilatation of the ascending aorta (HP:0005111) | 1.92150916 |
123 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.91623088 |
124 | Purpura (HP:0000979) | 1.90586087 |
125 | Hematochezia (HP:0002573) | 1.88586771 |
126 | Hypoglycemic coma (HP:0001325) | 1.88586418 |
127 | Broad metatarsal (HP:0001783) | 1.88220449 |
128 | Abnormality of the nasal mucosa (HP:0000433) | 1.88044949 |
129 | Hyperglycinemia (HP:0002154) | 1.88001228 |
130 | Ovoid vertebral bodies (HP:0003300) | 1.87845106 |
131 | Arterial thrombosis (HP:0004420) | 1.86479383 |
132 | Increased connective tissue (HP:0009025) | 1.85107320 |
133 | Abnormality of the Achilles tendon (HP:0005109) | 1.84698646 |
134 | Menorrhagia (HP:0000132) | 1.84639395 |
135 | Shallow orbits (HP:0000586) | 1.84075978 |
136 | Spondylolisthesis (HP:0003302) | 1.83451935 |
137 | Hand muscle atrophy (HP:0009130) | 1.83367473 |
138 | Skin nodule (HP:0200036) | 1.83225589 |
139 | Spastic diplegia (HP:0001264) | 1.83022687 |
140 | Pulmonary embolism (HP:0002204) | 1.82911781 |
141 | Spontaneous hematomas (HP:0007420) | 1.82328816 |
142 | Glomerulonephritis (HP:0000099) | 1.81862564 |
143 | Abnormal cartilage morphology (HP:0002763) | 1.81233307 |
144 | Increased IgE level (HP:0003212) | 1.80959265 |
145 | Malnutrition (HP:0004395) | 1.80898356 |
146 | Interstitial pulmonary disease (HP:0006530) | 1.79142872 |
147 | Ankle contracture (HP:0006466) | 1.78832256 |
148 | Hemiplegia (HP:0002301) | 1.78798363 |
149 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.77965430 |
150 | Hypochromic anemia (HP:0001931) | 1.77150465 |
151 | Atrophic scars (HP:0001075) | 1.76475380 |
152 | Thrombophlebitis (HP:0004418) | 1.73597934 |
153 | Abnormality of nucleobase metabolism (HP:0010932) | 1.73092905 |
154 | Diplopia (HP:0000651) | 1.71635091 |
155 | Abnormality of binocular vision (HP:0011514) | 1.71635091 |
156 | Abnormality of the pleura (HP:0002103) | 1.71612528 |
157 | Gout (HP:0001997) | 1.71531104 |
158 | Episodic fever (HP:0001954) | 1.71262592 |
159 | Abnormal foot bone ossification (HP:0010675) | 1.71029762 |
160 | Mesangial abnormality (HP:0001966) | 1.70479645 |
161 | Increased CSF protein (HP:0002922) | 1.70242787 |
162 | Protuberant abdomen (HP:0001538) | 1.69826965 |
163 | Decreased circulating renin level (HP:0003351) | 1.69449132 |
164 | Leukocytosis (HP:0001974) | 1.69365471 |
165 | Axonal loss (HP:0003447) | 1.68025185 |
166 | Back pain (HP:0003418) | 1.66682426 |
167 | Colitis (HP:0002583) | 1.66479947 |
168 | Cervical subluxation (HP:0003308) | 1.66118730 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 4.67672595 |
2 | ERN1 | 4.01516909 |
3 | PKN2 | 3.22871614 |
4 | RIPK4 | 3.16757747 |
5 | FGFR4 | 2.94322964 |
6 | SIK1 | 2.89209522 |
7 | MAP4K1 | 2.73322743 |
8 | EPHB1 | 2.22698966 |
9 | EEF2K | 2.19587454 |
10 | TYK2 | 2.12646319 |
11 | TTN | 2.08264420 |
12 | MAP3K10 | 2.04621218 |
13 | PTK6 | 1.98785774 |
14 | RIPK1 | 1.95730249 |
15 | PRPF4B | 1.92993498 |
16 | TNK2 | 1.73517021 |
17 | MAP3K3 | 1.66505196 |
18 | JAK3 | 1.63807524 |
19 | TGFBR2 | 1.62130148 |
20 | BCKDK | 1.58999178 |
21 | JAK1 | 1.58881669 |
22 | MAPK15 | 1.52194923 |
23 | TBK1 | 1.51771082 |
24 | LRRK2 | 1.51390266 |
25 | STK10 | 1.51262043 |
26 | CDC42BPA | 1.48511806 |
27 | TAOK2 | 1.47973457 |
28 | FGFR3 | 1.47227505 |
29 | ZAP70 | 1.46471320 |
30 | CDK12 | 1.45945480 |
31 | MAP2K3 | 1.38468521 |
32 | FES | 1.35925467 |
33 | MAP2K6 | 1.34617850 |
34 | MARK2 | 1.33803895 |
35 | MAP3K14 | 1.33672881 |
36 | GRK6 | 1.32591148 |
37 | PRKD2 | 1.31620158 |
38 | MST1R | 1.24597080 |
39 | LATS1 | 1.22688199 |
40 | CAMK1D | 1.22236218 |
41 | BMX | 1.18489333 |
42 | IRAK4 | 1.17739999 |
43 | ITK | 1.16177287 |
44 | EPHA3 | 1.14614301 |
45 | CAMK1G | 1.11638046 |
46 | MAP3K7 | 1.11513422 |
47 | TAOK3 | 1.10098014 |
48 | CSK | 1.08544528 |
49 | TAOK1 | 1.05919595 |
50 | IKBKE | 1.03759933 |
51 | PDGFRA | 1.03736407 |
52 | MAPK7 | 1.02358890 |
53 | JAK2 | 1.01850107 |
54 | FGFR2 | 0.97314942 |
55 | HIPK2 | 0.94613296 |
56 | CHUK | 0.91388501 |
57 | PTK2 | 0.89760182 |
58 | DAPK2 | 0.88854220 |
59 | HCK | 0.86557661 |
60 | NEK9 | 0.82828301 |
61 | BTK | 0.82576875 |
62 | RPS6KA2 | 0.82524284 |
63 | MTOR | 0.81347403 |
64 | CDK6 | 0.79460147 |
65 | IRAK3 | 0.79378499 |
66 | FLT3 | 0.77884828 |
67 | PRKCH | 0.77525394 |
68 | CAMKK1 | 0.77439004 |
69 | RPS6KA4 | 0.75843911 |
70 | LYN | 0.75378904 |
71 | FRK | 0.74793625 |
72 | IRAK1 | 0.74264182 |
73 | IKBKB | 0.72646799 |
74 | PDGFRB | 0.72558762 |
75 | RET | 0.72238391 |
76 | KSR2 | 0.70645858 |
77 | DMPK | 0.70511073 |
78 | STK38 | 0.69975550 |
79 | WNK1 | 0.69363104 |
80 | MAP3K13 | 0.68634472 |
81 | SIK3 | 0.68208342 |
82 | MAPK11 | 0.66400657 |
83 | PIM1 | 0.65476234 |
84 | TXK | 0.65194226 |
85 | FGFR1 | 0.64541461 |
86 | STK3 | 0.64018549 |
87 | FGR | 0.61740428 |
88 | PTK2B | 0.61051243 |
89 | BLK | 0.60555789 |
90 | EPHA2 | 0.60131674 |
91 | NLK | 0.59081719 |
92 | PIK3CG | 0.58643085 |
93 | CSF1R | 0.56969388 |
94 | SGK3 | 0.56787948 |
95 | MAP3K6 | 0.56740506 |
96 | MAP3K11 | 0.56553713 |
97 | TRPM7 | 0.55799199 |
98 | LCK | 0.55677546 |
99 | PAK2 | 0.55416227 |
100 | ICK | 0.55236347 |
101 | DDR2 | 0.54352436 |
102 | RPS6KA6 | 0.53190863 |
103 | STK11 | 0.53070218 |
104 | PRKD3 | 0.52901724 |
105 | RPS6KL1 | 0.52330869 |
106 | RPS6KC1 | 0.52330869 |
107 | TLK1 | 0.51800623 |
108 | TYRO3 | 0.50966160 |
109 | MARK3 | 0.50218779 |
110 | PDK1 | 0.50077343 |
111 | MAP3K1 | 0.49914224 |
112 | MAP3K2 | 0.48965290 |
113 | PRKG2 | 0.48351949 |
114 | MAPK12 | 0.47976621 |
115 | SYK | 0.47394631 |
116 | ACVR1B | 0.47110545 |
117 | PAK4 | 0.47083751 |
118 | PDPK1 | 0.46541700 |
119 | ADRBK2 | 0.46335839 |
120 | FYN | 0.46335365 |
121 | BMPR2 | 0.45432604 |
122 | PRKAA2 | 0.45367797 |
123 | CDK4 | 0.42994289 |
124 | MAPKAPK3 | 0.42707259 |
125 | ALK | 0.42180115 |
126 | KIT | 0.41775466 |
127 | DYRK1B | 0.40837402 |
128 | GSK3A | 0.39585655 |
129 | SIK2 | 0.37704076 |
130 | KDR | 0.37500029 |
131 | EGFR | 0.37089547 |
132 | PRKCQ | 0.37056857 |
133 | MAP3K8 | 0.36292306 |
134 | PRKD1 | 0.35533022 |
135 | MAP2K2 | 0.35212426 |
136 | STK24 | 0.34742620 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.18072162 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.07461890 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.86032892 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.61836036 |
5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.43404181 |
6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.36211385 |
7 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.28671236 |
8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.27277473 |
9 | Other glycan degradation_Homo sapiens_hsa00511 | 2.23676692 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.20071191 |
11 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.09123977 |
12 | Allograft rejection_Homo sapiens_hsa05330 | 1.90239636 |
13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.84928811 |
14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.83790383 |
15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.83260183 |
16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.79830175 |
17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.79596176 |
18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.74456369 |
19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.66951779 |
20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.58296998 |
21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.50471441 |
22 | Asthma_Homo sapiens_hsa05310 | 1.49822416 |
23 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.42892377 |
24 | Bile secretion_Homo sapiens_hsa04976 | 1.36858668 |
25 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.35263360 |
26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.33619217 |
27 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.32752670 |
28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.24144060 |
29 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.24018655 |
30 | Peroxisome_Homo sapiens_hsa04146 | 1.21489697 |
31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.19545111 |
32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.15687697 |
33 | Lysine degradation_Homo sapiens_hsa00310 | 1.14151161 |
34 | Histidine metabolism_Homo sapiens_hsa00340 | 1.14033022 |
35 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.09850788 |
36 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.09295347 |
37 | Insulin resistance_Homo sapiens_hsa04931 | 1.08352236 |
38 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.07883971 |
39 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.07480457 |
40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.06951024 |
41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.06739173 |
42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.06373028 |
43 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.06365651 |
44 | ABC transporters_Homo sapiens_hsa02010 | 1.06193429 |
45 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.05084427 |
46 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.04420771 |
47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.03147751 |
48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.03129147 |
49 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.98717165 |
50 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.96640254 |
51 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.96305815 |
52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.95972998 |
53 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.95391016 |
54 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.94719889 |
55 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.94116677 |
56 | Leishmaniasis_Homo sapiens_hsa05140 | 0.92468138 |
57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.92251932 |
58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.90711537 |
59 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.88694384 |
60 | Retinol metabolism_Homo sapiens_hsa00830 | 0.88522783 |
61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.87774849 |
62 | Carbon metabolism_Homo sapiens_hsa01200 | 0.86470577 |
63 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.86225857 |
64 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.85913288 |
65 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.85335316 |
66 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.83485923 |
67 | Platelet activation_Homo sapiens_hsa04611 | 0.82706580 |
68 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.82609537 |
69 | Phagosome_Homo sapiens_hsa04145 | 0.82519292 |
70 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.82251146 |
71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81039353 |
72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80762082 |
73 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.79683207 |
74 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.79241978 |
75 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.79221999 |
76 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.77462103 |
77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.76744853 |
78 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.75711335 |
79 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.75226550 |
80 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.73989489 |
81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.73933720 |
82 | Amoebiasis_Homo sapiens_hsa05146 | 0.71177785 |
83 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.71017908 |
84 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.70368461 |
85 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.69336291 |
86 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.68398661 |
87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67482017 |
88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.67307920 |
89 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.66960471 |
90 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.66587729 |
91 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.66512394 |
92 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.66327338 |
93 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.65228487 |
94 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64466630 |
95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.63953658 |
96 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.63940741 |
97 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.62654131 |
98 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.62206162 |
99 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.60478027 |
100 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.60015380 |
101 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.59785254 |
102 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.59611615 |
103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58496545 |
104 | Mineral absorption_Homo sapiens_hsa04978 | 0.58269712 |
105 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.57727028 |
106 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57339624 |
107 | Lysosome_Homo sapiens_hsa04142 | 0.56327810 |
108 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.56233188 |
109 | Measles_Homo sapiens_hsa05162 | 0.56083112 |
110 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.54988488 |
111 | Focal adhesion_Homo sapiens_hsa04510 | 0.54534824 |
112 | Malaria_Homo sapiens_hsa05144 | 0.54478785 |
113 | Viral myocarditis_Homo sapiens_hsa05416 | 0.53021218 |
114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51938419 |
115 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.51512303 |
116 | Sulfur relay system_Homo sapiens_hsa04122 | 0.51506601 |
117 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.51467639 |
118 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.51061491 |
119 | Hepatitis B_Homo sapiens_hsa05161 | 0.50640107 |
120 | Legionellosis_Homo sapiens_hsa05134 | 0.50602156 |
121 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.50542029 |
122 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.49958919 |
123 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.49897182 |
124 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49692557 |
125 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48980476 |
126 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.47908389 |
127 | Endocytosis_Homo sapiens_hsa04144 | 0.47673960 |
128 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.47440551 |
129 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.47228761 |
130 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47218316 |
131 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.46089288 |
132 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.45625375 |
133 | Hepatitis C_Homo sapiens_hsa05160 | 0.45622707 |
134 | Renin secretion_Homo sapiens_hsa04924 | 0.45090907 |
135 | Pertussis_Homo sapiens_hsa05133 | 0.45071115 |
136 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.44962710 |
137 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44520592 |
138 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.44479610 |
139 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.44459197 |
140 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.44458546 |
141 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.44213658 |
142 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.43340860 |
143 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.43045930 |
144 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.42926127 |
145 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.42726722 |
146 | Tuberculosis_Homo sapiens_hsa05152 | 0.41827970 |
147 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.40844332 |
148 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.40117060 |
149 | Apoptosis_Homo sapiens_hsa04210 | 0.39163503 |
150 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.38749644 |
151 | Influenza A_Homo sapiens_hsa05164 | 0.37927403 |
152 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.37633548 |
153 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.36742406 |
154 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.36275048 |
155 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.35962194 |